You H, Zhang H, Jin X, Yan Z
Front Genet. 2025; 15:1453191.
PMID: 39748950
PMC: 11693700.
DOI: 10.3389/fgene.2024.1453191.
Wang F, Mehta P, Bach I
Biochem Soc Trans. 2024; 52(3):1099-1107.
PMID: 38747697
PMC: 11346418.
DOI: 10.1042/BST20230573.
Farooqi A, Rakhmetova V, Kapanova G, Tanbayeva G, Mussakhanova A, Abdykulova A
Cells. 2023; 12(19).
PMID: 37830596
PMC: 10571945.
DOI: 10.3390/cells12192382.
Wu Q, Yin J, Jiang M, Zhang J, Sui Z
BMC Genomics. 2023; 24(1):549.
PMID: 37723489
PMC: 10506303.
DOI: 10.1186/s12864-023-09639-0.
Yan W, Zhong Y, Hu X, Xu T, Zhang Y, Kales S
Nat Commun. 2023; 14(1):4798.
PMID: 37558718
PMC: 10412574.
DOI: 10.1038/s41467-023-40537-x.
Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome.
Culletta G, Tutone M, Ettari R, Perricone U, Di Chio C, Almerico A
Int J Mol Sci. 2023; 24(13).
PMID: 37445688
PMC: 10341482.
DOI: 10.3390/ijms241310504.
Synthesis and Preliminary Characterization of Putative Anle138b-Centered PROTACs against α-Synuclein Aggregation.
Pedrini M, Iannielli A, Meneghelli L, Passarella D, Broccoli V, Seneci P
Pharmaceutics. 2023; 15(5).
PMID: 37242709
PMC: 10221781.
DOI: 10.3390/pharmaceutics15051467.
Protein Aggregates and Aggrephagy in Myopathies.
Gibertini S, Ruggieri A, Cheli M, Maggi L
Int J Mol Sci. 2023; 24(9).
PMID: 37176163
PMC: 10179229.
DOI: 10.3390/ijms24098456.
Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox.
Siepe D, Picton L, Garcia K
ACS Synth Biol. 2023; 12(4):1081-1093.
PMID: 37011906
PMC: 10127277.
DOI: 10.1021/acssynbio.2c00587.
The Absence of FAIM Leads to a Delay in Dark Adaptation and Hampers Arrestin-1 Translocation upon Light Reception in the Retina.
Sires A, Pazo-Gonzalez M, Lopez-Soriano J, Mendez A, de la Rosa E, de la Villa P
Cells. 2023; 12(3).
PMID: 36766830
PMC: 9914070.
DOI: 10.3390/cells12030487.
FMRP, FXR1 protein and Dlg4 mRNA, which are associated with fragile X syndrome, are involved in the ubiquitin-proteasome system.
Shimizu H, Hohjoh H
Sci Rep. 2023; 13(1):1956.
PMID: 36732356
PMC: 9894842.
DOI: 10.1038/s41598-023-29152-4.
Disulfide-containing polymer delivery of C527 and a Platinum(IV) prodrug selectively inhibited protein ubiquitination and tumor growth on cisplatin resistant and patient-derived liver cancer models.
Shang K, Zhang L, Yu Y, Xiao H, Gao Y, Yang L
Mater Today Bio. 2023; 18:100548.
PMID: 36713799
PMC: 9874064.
DOI: 10.1016/j.mtbio.2023.100548.
OTU7B Modulates the Mosquito Immune Response to Beauveria bassiana Infection via Deubiquitination of the Toll Adaptor TRAF4.
Wang Y, Chang M, Wang M, Ji Y, Sun X, Raikhel A
Microbiol Spectr. 2022; 11(1):e0312322.
PMID: 36537797
PMC: 9927300.
DOI: 10.1128/spectrum.03123-22.
Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer.
Jayaprakash S, Hegde M, BharathwajChetty B, Girisa S, AlQahtani M, Abbas M
Int J Mol Sci. 2022; 23(20).
PMID: 36293239
PMC: 9604169.
DOI: 10.3390/ijms232012380.
Novel Class of Proteasome Inhibitors: In Silico and In Vitro Evaluation of Diverse Chloro(trifluoromethyl)aziridines.
Ielo L, Patamia V, Citarella A, Efferth T, Shahhamzehei N, Schirmeister T
Int J Mol Sci. 2022; 23(20).
PMID: 36293216
PMC: 9603864.
DOI: 10.3390/ijms232012363.
Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease.
Roca-Lema D, Quiroga M, Khare V, Diaz-Diaz A, Barreiro-Alonso A, Rodriguez-Alonso A
Sci Rep. 2022; 12(1):17571.
PMID: 36266428
PMC: 9584894.
DOI: 10.1038/s41598-022-22295-w.
Structural insight into UV-B-activated UVR8 bound to COP1.
Wang Y, Wang L, Guan Z, Chang H, Ma L, Shen C
Sci Adv. 2022; 8(16):eabn3337.
PMID: 35442727
PMC: 9020657.
DOI: 10.1126/sciadv.abn3337.
EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer.
Wang J, Wren J, Ding Y, Chen J, Mittal N, Xu C
Cancer Lett. 2022; 536:215641.
PMID: 35339615
PMC: 9036562.
DOI: 10.1016/j.canlet.2022.215641.
Overcoming drug resistance by targeting protein homeostasis in multiple myeloma.
Moscvin M, Ho M, Bianchi G
Cancer Drug Resist. 2022; 4:1028-1046.
PMID: 35265794
PMC: 8903187.
DOI: 10.20517/cdr.2021.93.
NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma.
Huang X, Cao W, Yao S, Chen J, Liu Y, Qu J
Cell Death Dis. 2022; 13(3):197.
PMID: 35236820
PMC: 8891287.
DOI: 10.1038/s41419-022-04629-8.